JPM Day 2: Highlights

5:15 p.m.: The last time Relay Therapeutics CEO Sanjiv Patel presented at JP Morgan week, it was as the head of a preclinical company. On Tuesday, he showcased a pipeline of six candidates, three of them in early-to-mid clinical development. 2023, he said, is “all about execution.”